Go to the list of all blogs
published in Blogs
Jul 16, 2026
VIXY: Targeting $30 with +40-45% Upside in the Next Volatility Move

VIXY: Targeting $30 with +40-45% Upside in the Next Volatility Move

Key Takeaways

  • Target price: $30 per share, representing a roughly 40-45% gain from recent levels near $21, a round psychological level the ETF has crossed multiple times over the past year.
  • Strongest bullish factor: A sudden spike in equity market volatility — driven by geopolitical shock, recession fears, or a rapid equity sell-off — would directly lift VIX futures prices and propel VIXY higher.
  • Biggest obstacle: Contango, the persistent condition where longer-dated VIX futures trade above near-term contracts, imposes a structural cost every time the fund rolls positions, eroding the ETF's value during calm markets.
  • Key levels: The $20 area marks an important psychological and technical support zone near the 52-week low, while $30-$35 represents a resistance band that has capped rallies during moderate volatility events.
  • Investor takeaway: Hitting $30 is realistic during the next volatility spike, but VIXY is designed for short-term tactical use and structurally decays during extended calm — making timing the critical variable.

What VIXY Actually Tracks

The ProShares VIX Short-Term Futures ETF (VIXY) is an exchange-traded fund that tracks the S&P 500 VIX Short-Term Futures Index. Unlike a traditional equity ETF, VIXY does not hold shares of companies. Instead, it invests in a rolling portfolio of first- and second-month VIX futures contracts — financial instruments that reflect market expectations for S&P 500 volatility 30 days into the future.

This distinction matters enormously. VIXY does not track the spot Cboe Volatility Index (VIX) directly, and its performance can diverge significantly from the headline VIX number that traders watch. The fund resets exposure daily and is intended for short-term use — often measured in days or weeks, not months or years. ProShares explicitly warns that investors holding shares over longer periods "may be subject to increased risk of loss."

Where VIXY Stands Today

As of mid-July 2026, VIXY trades near $21, hovering just above its 52-week low of approximately $20.28. The ETF has declined roughly 55% over the past twelve months, consistent with a prolonged period of relatively subdued equity market volatility. The fund's assets under management (AUM) stand at approximately $198 million, with an expense ratio of 0.85% to 0.96% depending on the reporting source.

VIXY's 52-week high reached approximately $46.89, demonstrating the ETF's capacity for explosive upside moves when volatility regimes shift. The current price, sitting near the low end of this range, means a move to $30 would require recovering roughly half the distance between the 52-week low and that prior peak — a plausible scenario during elevated but not extreme market stress.

Catalysts That Could Push VIXY Toward $30

VIXY rallies when fear enters equity markets. The most direct catalyst would be a sharp S&P 500 drawdown — on the order of 5% to 10% — triggered by any of several realistic scenarios. An unexpectedly hawkish Federal Reserve pivot, disappointing earnings from mega-cap technology stocks, escalating trade tensions, or a geopolitical crisis could all send the VIX futures curve sharply higher.

Historical precedent supports the plausibility. During the most recent significant volatility events over the past year, VIXY surged from levels similar to today's into the $30-$47 range within days or weeks. The ETF's structure means that when spot VIX spikes and the futures curve shifts upward in backwardation — where near-term futures rise above longer-dated ones — VIXY can deliver rapid gains. A VIX reading moving from the mid-teens into the mid-to-high 20s would likely be sufficient to push VIXY toward the $30 level.

Market sentiment and positioning also play a role. Periods of extreme complacency, when volatility selling strategies become crowded, can set the stage for violent reversals. When the market is positioned for continued calm, even a moderate catalyst can trigger outsized moves in volatility products as traders rush to hedge.

The Main Headwind: Contango and Structural Decay

The single largest headwind is contango. In normal market conditions, longer-dated VIX futures trade at a premium to near-term contracts because uncertainty increases with time. Each day, VIXY must sell expiring front-month contracts and buy more expensive second-month contracts — a process that steadily erodes the fund's net asset value. This structural decay means VIXY can decline even when the spot VIX remains flat.

Additionally, the macroeconomic backdrop matters. If the U.S. economy continues expanding, corporate earnings hold steady, and the Fed maintains a predictable policy path, equity volatility could remain suppressed for extended periods. In that environment, VIXY would continue grinding lower rather than mounting a recovery toward $30. The fund has lost roughly 47% annualized over the past five years, illustrating how punishing a "buy and hold" approach can be.

Liquidity and fund flows represent another consideration. VIXY competes with leveraged volatility products, and its approximately $198 million in AUM is modest by ETF standards. During extreme market dislocations, the underlying VIX futures market can experience strained liquidity, potentially causing the ETF to trade at premiums or discounts to its net asset value.

Important Technical Levels to Watch

From a technical analysis perspective, the $20 zone represents a critical support area — the floor established during the most recent period of market calm. A break below this level would signal a new leg lower and likely delay any path to $30. On the upside, $25 serves as the first meaningful hurdle, followed by the psychologically important $30 round number. The $35-$38 area marks stronger resistance based on previous consolidation patterns observed during moderate volatility episodes over the past year.

Because VIXY is a derivative-based product rather than a company with earnings, traditional valuation metrics such as price-to-earnings ratios (P/E) or earnings per share (EPS) do not apply. The "valuation" is entirely a function of VIX futures pricing, market expectations for volatility, and the slope of the futures curve.

Using AI Daily Buy/Sell Signals for Better Timing

Navigating a product as fast-moving as VIXY requires disciplined timing. AI Daily Buy/Sell Signals from Tickeron provide traders with a systematic, data-driven approach to identifying opportunities across thousands of stocks and ETFs. The platform's artificial intelligence continuously monitors market conditions, technical patterns, and trend shifts to generate actionable Buy, Sell, or Hold signals. For volatility products like VIXY, where entry and exit timing can make the difference between profit and loss, having an AI-powered monitoring tool helps traders stay ahead of rapid sentiment changes without staring at screens all day. Traders can use these signals to screen for new opportunities, manage existing positions, and spot emerging trend changes more efficiently.

Putting It All Together

The question of whether VIXY can reach $30 is not a matter of "if" but rather "when" and "how quickly." The ETF has demonstrated repeatedly that it can surge to $30 and well beyond during volatility events. The structural drag of contango makes sustained moves higher unlikely without fresh market fear, and timing the entry remains the central challenge. Investors watching VIXY should monitor the VIX futures curve structure, macroeconomic catalysts, and equity market sentiment as leading indicators. A move to $30 appears realistic during the next meaningful volatility spike, but investors must recognize that this ETF is a tactical instrument, not a long-term holding, and carries the real risk of permanent capital decay if held through extended calm periods.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: VIXY

VIXY in +1.23% Uptrend, rising for three consecutive days on August 18, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where VIXY advanced for three days, in of 192 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for VIXY's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 14 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 31, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VIXY as a result. In of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for VIXY turned negative on August 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VIXY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VIXY broke above its upper Bollinger Band on July 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for VIXY entered a downward trend on July 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Industry description

The investment seeks investment results, before fees and expenses, that over time, match the performance of the S&P 500 VIX Short-Term Futures Index for a single day. The index seeks to offer exposure to market volatility through publicly traded futures markets and is designed to measure the implied volatility of the S&P 500 over 30 days in the future.
View a ticker or compare two or three
VIXY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Details
Category
Trading--Miscellaneous
Address
ProShares Trust II7501 WISCONSIN AVEBethesda
Phone
240-497-6400
Web
www.proshares.com
Interact to see
Advertisement
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Intercontinental Exchange (ICE) has navigated recent market volatility while remaining within its 52-week range. Broader weakness in financial data and exchange operators has created short-term pressure, but ICE’s diversified business model continues to provide stability.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.